Unofficial. This site is an experimental reformatting of data published by NHS England. It is not endorsed by NHS England. Always check the official Data Uses Register before relying on anything here.

Covid-19 UK Non-hospital Antibody Testing Results (Pillar 3)

Agreements naming it
12
In term in September 2026
9
Organisations
9
Files released
16

Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.

How the register describes it

Recorded against the dataset on each agreement, and not always the same from one agreement to the next, so every value found is listed.

Type of data
  • Anonymised - ICO Code Compliant
  • Identifiable
Sensitivity
  • Non-Sensitive
  • Sensitive
Frequency of release
  • One-Off
  • Ongoing
  • System Access
Legal basis for provision
  • CV19: Regulation 3 (4) of the Health Service (Control of Patient Information) Regulations 2002
  • Health and Social Care Act 2012 - s261 - 'Other dissemination of information'
  • Health and Social Care Act 2012 - s261(5)(c)
  • Health and Social Care Act 2012 - s261(5)(d)
  • Health and Social Care Act 2012 – s261(2)(a)
  • Health and Social Care Act 2012 – s261(2)(c)
  • Health and Social Care Act 2012 – s261(7)
  • National Health Service Act 2006 - s251 - 'Control of patient information'.
3 more
  • Other-NHS (Control of Patient Information) Regulations 2002 - regulation 3
  • Other-National Health Service Act 2006 - s251
  • Other-Regulation 3 of The Health Service (Control of Patient Information) Regulations 2002

Organisations whose agreements name it (9)

Show the list, with the number of agreements for each

With an agreement in term in September 2026 (7)

With expired agreements only (2)

Agreements covering this dataset

Showing all 12 agreements.

Files: files of this dataset released under the agreement, across all its versions.

Agreements covering Covid-19 UK Non-hospital Antibody Testing Results (Pillar 3)
AgreementOrganisationTypeFilesLatest termStatusCommercial
Real-world effectiveness and safety of the Oxford/AstraZeneca covid-19 vaccine ***and investigation of the epidemiology of thrombotic thrombocytopenia and other adverse events of interest following COVID-19 vaccination*** in England: ORCHID linkage DARS-NIC-459114-J3C1F University of Oxford Academic 10 17 April 2025 to 16 April 2030 In term Yes
D1.1 - UK Health Security Agency (UKHSA) Single Data Sharing Agreement DARS-NIC-343380-H5Q9K UK Health Security Agency Agency/Public Body 0 13 March 2026 to 12 March 2029 In term No
Department of Health and Social Care (DHSC) SDE access - Enabling Policy Analysis DARS-NIC-484452-H8S1L Department of Health and Social Care Ministerial Department 0 11 July 2025 to 24 April 2028 In term No
University of Bristol - Longitudinal Linkage Collaboration - COPI Reg 3 DARS-NIC-420168-K4N1F University of Bristol Academic 0 29 May 2026 to 28 May 2027 In term No
University of Bristol - Longitudinal Linkage Collaboration - s251 cohort DARS-NIC-420229-G9H9S University of Bristol Academic 1 29 May 2026 to 31 March 2027 In term No
UK Longitudinal Linkage Collaboration (UK LLC) - Consent DARS-NIC-748729-Z8B3M University of Bristol Academic 1 23 March 2026 to 22 March 2027 In term No
INTERVAL, COMPARE and STRIDES Bio Resource trial cohorts: Long-term follow up of health outcomes and associations with genetic, biological and lifestyle traits DARS-NIC-156334-711SX University of Cambridge Academic 2 11 February 2026 to 26 February 2027 In term Yes
R14.2 - COVID-IMPACT-UK. Health conditions and COVID19: using UK-wide linked routine healthcare data to address the impact of health conditions on COVID-19 and the impact of COVID-19 on health conditions. DARS-NIC-381078-Y9C5K Health Data Research UK Academic 0 19 December 2025 to 31 January 2027 In term No
Imperial College London - REACT Data and Connectivity National Core Studies DARS-NIC-431352-G7F1M Imperial College London Academic 2 16 January 2026 to 15 January 2027 In term No
Real-world effectiveness of the Oxford/AstraZeneca covid-19 vaccine and investigation of the epidemiology of thrombotic thrombocytopenia and other adverse events of interest following COVID-19 vaccination in England - SDE Analysis DARS-NIC-445543-W0D4N AstraZeneca UK Limited Commercial 0 7 July 2023 to 31 December 2023 Expired Yes
CV19DR1 Department of Health & Social Care – Test and Trace Programme DARS-NIC-406871-Q9G2Q Department of Health and Social Care Ministerial Department 0 1 October 2022 to 31 December 2022 Expired No
R11, R11.1, R11.2 - Convalescent Plasma Program (Serum trial) DARS-NIC-372791-X0H3Q NHS Blood and Transplant (NHSBT) Agency/Public Body 0 16 December 2020 to 31 March 2021 Expired No

Cite this page

NHS England (2026) Data Uses Register, September 2026 edition, agreements naming Covid-19 UK Non-hospital Antibody Testing Results (Pillar 3). Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/datasets/covid-19-uk-non-hospital-antibody-testing-results-pillar-3/ (accessed [date]).

This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.